The price of Zytiga 250 mg varies by pharmacy and insurance coverage, but it is generally a high-cost medication. For example, Zytiga 250 mg is listed at $9,195.01 for 120 tablets at one online pharmacy, though a discount of $7,000 is available, bringing the cost down to $2,195.01 [1]. Another source indicates a price of $10,407.20 for 120 tablets [2].
How can I lower the cost of Zytiga?
Patients may be able to reduce their out-of-pocket expenses for Zytiga through various means. The manufacturer, Janssen, offers a Zytiga Co-Pay Program that can help eligible patients with prescription costs. This program may reduce co-pays to as little as $0 for commercially insured patients who meet certain criteria [3]. For those without insurance or with inadequate coverage, generic versions of abiraterone acetate, the active ingredient in Zytiga, are available and typically cost less [4]. Patient assistance programs and discount cards can also offer savings [1, 5].
When does Zytiga's patent expire?
The patent exclusivity for Zytiga has largely expired in major markets, paving the way for generic competition. In the United States, patents began expiring around 2018, with subsequent litigation and approvals of generic versions [6]. In Europe, patent expiries also occurred around the same timeframe, leading to the introduction of generic abiraterone acetate [7]. DrugPatentWatch.com tracks patent expiration dates for many medications, including Zytiga [8].
What are the generic alternatives to Zytiga?
Generic versions of abiraterone acetate are available and are considered therapeutically equivalent to Zytiga. These generics offer a lower-cost alternative for patients and healthcare providers [4, 7]. The availability of these generics has significantly impacted the market by increasing access to abiraterone acetate treatment [6].
How does Zytiga work?
Zytiga, with the active ingredient abiraterone acetate, is a type of androgen biosynthesis inhibitor. It works by blocking an enzyme called CYP17A1, which is necessary for the production of androgens. Androgens are hormones that can fuel prostate cancer growth. By reducing androgen levels, abiraterone acetate helps to slow down the progression of prostate cancer, particularly in cases that are hormone-refractory or metastatic [9].
What is Zytiga used to treat?
Zytiga is used to treat prostate cancer. It is prescribed for men with metastatic castration-resistant prostate cancer (mCRPC) who have not yet received docetaxel chemotherapy [9]. It is also indicated for patients with mCRPC who have previously received docetaxel [10].
Who makes Zytiga?
Zytiga was originally developed and marketed by Cougar Biotechnology, which was later acquired by Johnson & Johnson's subsidiary, Janssen Pharmaceuticals. Therefore, Janssen is the primary manufacturer associated with Zytiga [9].
What are the side effects of Zytiga?
Common side effects associated with Zytiga treatment include fatigue, joint pain, nausea, hot flashes, diarrhea, and high blood pressure. More serious side effects can include liver problems, adrenal insufficiency, and fluid retention, which can lead to conditions like heart failure [9]. It is important for patients to discuss potential side effects with their healthcare provider.
What clinical trials have been conducted for Zytiga?
Extensive clinical trials have evaluated Zytiga's efficacy and safety in various prostate cancer settings. Key trials include the COU-AA-301 study for patients who had progressed on docetaxel-based chemotherapy and the COU-AA-302 study for men with asymptomatic or minimally symptomatic mCRPC who had not yet received chemotherapy [9]. These trials demonstrated significant improvements in overall survival and other endpoints for patients treated with Zytiga.
How does abiraterone acetate work compared to other prostate cancer treatments?
Abiraterone acetate functions by inhibiting androgen production at multiple sites, including the testes, adrenal glands, and within the tumor itself. This mechanism differs from older forms of hormone therapy that primarily targeted the pituitary gland to reduce luteinizing hormone (LH) production, thereby reducing testicular androgen synthesis. By more comprehensively suppressing androgen levels, abiraterone acetate can be effective even when other hormonal therapies are no longer sufficient [9].
What is the difference between Zytiga and generic abiraterone acetate?
Zytiga is the brand-name medication, while generic abiraterone acetate refers to the chemically identical drug produced by other pharmaceutical companies after patent expiry. Both contain the same active ingredient and are expected to have the same therapeutic effect. Generic versions are typically manufactured and sold at a lower cost due to the absence of brand-name research and development expenses [4, 7].
What is the recommended dosage for Zytiga?
The recommended dosage for Zytiga is 1000 mg taken orally once daily [9]. It is typically administered in combination with a corticosteroid, such as prednisone, to help manage potential side effects like fluid retention and hypokalemia. Zytiga should be taken on an empty stomach, at least one hour before or two hours after a meal [3, 9].
Sources:
[1] https://www.goodrx.com/zytiga
[2] https://www.drugs.com/price-guide/zytiga
[3] https://www.zytiga.com/savings-support
[4] https://www.goodrx.com/abiraterone-acetate
[5] https://www.pharmacychecker.com/drug/zytiga/
[6] https://www.drugpatentwatch.com/blog/zytiga-abiraterone-acetate-patent-expiration-dates-and-generic-launch-analysis
[7] https://www.drugpatentwatch.com/blog/european-patent-landscape-for-abiraterone-acetate-generic-opportunities
[8] https://www.drugpatentwatch.com/
[9] https://www.janssen.com/us/our-products/oncology/zytiga
[10] https://www.ncbi.nlm.nih.gov/books/NBK548583/